Organisation
Department of Pharmaceutics
Department
Current researchers
61 - 70 of 120 results
- Charlotte Hinnekens (Member)
- Baihao Huang (Member)
- Izet Karalic (Member)
- Sabah Kasmi (Member)
- Lars Koeken (Member)
- Simon Krols (Member)
- Christine Labeur (Member)
- Eileen Lambrechts (Member)
- Manon Lammens (Member)
- Heleen Lauwers (Member)
Projects
61 - 70 of 375
- Exploration of an mRNA based nanovaccine platform and immunopeptidomics for the development of more effective tuberculosis vaccines.From1 Nov 2022 → TodayFunding: FWO Strategic Basic Research Grant
- A novel CRISPR/Cas9-based nanomedicine strategy targeting CD4+ cells to cure HIVFrom1 Nov 2022 → TodayFunding: FWO Strategic Basic Research Grant
- Exploring and advancing mRNA lipid nanoparticles for the in situ generation of CAR-MsFrom1 Nov 2022 → TodayFunding: FWO Strategic Basic Research Grant
- Orchestrating next-generation mobile modular laboratories for pandemic monitoring preparednessFrom1 Oct 2022 → TodayFunding: Horizon Europe - Civil Security for Society
- Selective photoporation of the nuclear envelope to mimic pathological defects and facilitate intranuclear delivery.From1 Oct 2022 → TodayFunding: BOF - mobility
- A novel CRISPR/Cas9-based nanomedicine strategy targeting CD4+ cells to cure HIVFrom1 Oct 2022 → 31 Oct 2022Funding: BOF - doctoral mandates
- Non-covalent hapten-immunogen next generation anti-opioid nanovaccinesFrom1 Oct 2022 → TodayFunding: FWO junior postdoctoral fellowship
- Mechanobiology control of immunogenic cell death by bio-polymers for cancer therapyFrom1 Oct 2022 → TodayFunding: BOF - projects
- Pandemic preparedness: developing a multiplexed mass spectrometry assay to screen for pathogens and the induced immune response.From1 Oct 2022 → TodayFunding: FWO junior postdoctoral fellowship
- Understanding and modulating the pro-inflammatory activity of lipid nanoparticles (LNP) in the COVID-19 mRNA vaccines: towards the development of more effective LNP formulations.From1 Oct 2022 → TodayFunding: FWO senior postdoctoral fellowship
Publications
1 - 10 of 1927
- Synthesis and potency of novel uracil nucleotides and derivatives as P2Y(2) and P2Y(6) receptor agonists(2008)
Authors: HJ Ko, RL Carter, Liesbet Cosyn, R Petrelli, S de Castro, P Besada, YX Zhou, L Cappellacci, P Franchetti, M Grifantini, et al.
Pages: 6319 - 6332 - Human mitochondrial thymidine kinase is selectively inhibited by 3'-thiourea derivatives of beta-thymidine: identification of residues crucial for both inhibition and catalytic activity(2009)
Authors: Jan Balzarini, Ineke Van Daele, Ana Negri, Nicola Solaroli, Anna Karlsson, Sandra Liekens, Frederico Gago, Serge Van Calenbergh
Pages: 1127 - 1136 - ERS guidelines, statements and technical standards published in the ERJ in 2014: a year in review(2015)
Authors: Guy Brusselle, Mina Gaga
Pages: 863 - 866 - Real-life effectiveness of extrafine beclometasone dipropionate/formoterol in adults with persistent asthma according to smoking status(2012)
Authors: Guy Brusselle, Rudi Peché, Paul Van den Brande, Albert Verhulst, Wim Hollanders, Jacques Bruhwyler
Pages: 811 - 819 - Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns(2014)
Authors: David Price, Daniel West, Guy Brusselle, Kevin Gruffydd-Jones, Rupert Jones, Marc Miravitlles, Andrea Rossi, Catherine Hutton, Valerie L Ashton, Rebecca Stewart, et al.
Pages: 889 - 905 - Integrating real-life studies in the global therapeutic research framework(2013)
Authors: Nicolas Roche, Helen K Reddel, Alvar Agusti, Eric D Bateman, Jerry A Krishnan, Richard J Martin, Alberto Papi, Dirkje Postma, Mike Thomas, Guy Brusselle, et al.
Pages: e29 - e30 - The significance of eosinophilic inflammation in chronic obstructive pulmonary disease(2018)
Authors: Christopher B Cooper, Guy Brusselle, Steven J Pascoe, Ian D Pavord
Pages: 967 - 968 - InternationaL cross-sectIonAl and longItudinal assessment on aSthma cONtrol in European adult patients: the LIAISON study protocol(2013)
Authors: Fulvio Braido, Guy Brusselle, Eleonora Ingrassia, Gabriele Nicolini, David Price, Nicolas Roche, Joan B Soriano, Heinrich Worth
- Risk of a biased assessment of the evidence when limiting literature searches to the English language : macrolides in asthma as an illustrative example(2015)
Authors: Guy Brusselle, Francesco Blasi
Pages: 109 - 110 - Exacerbation rate reduction according to baseline blood eosinophilic count in patients with asthma treated with ICS/LABA maintenance and reliever therapy(2019)Volume: 199
Authors: Guy Brusselle, A Papi, G Nicolini, L Santoro, D Guastalla
Number of pages: 1